What is United Therapeutics Corp (UTHR)?
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address serious medical conditions. The company specializes in therapies for pulmonary arterial hypertension and other chronic and life-threatening diseases. Its operations encompass research, development, manufacturing, and marketing of pharmaceutical products. United Therapeutics employs advanced technologies and proprietary platforms to develop treatments that improve patient outcomes. The company maintains a pipeline of product candidates aimed at expanding its therapeutic reach. It operates manufacturing facilities and engages in collaborations to support its research and commercialization efforts. United Therapeutics is headquartered in the United States and serves a global market through its distribution networks.
United Therapeutics Corp Stock Price Today: Live Overview
The price today is shaped by live trading, as United Therapeutics Corp trades at $531.05. Its price during the session has moved between $522.16 and $538.92, with a daily change of -1.6455%.
FAQ: United Therapeutics Corp (UTHR)
What is the current price of UTHR stock?
The last recorded price is $531.05.
Does UTHR pay dividends?
United Therapeutics Corp pays dividends to its shareholders.
Does UTHR have a formal corporate presence or regional headquarters in the UAE?
United Therapeutics Corp does not have an official regional office or subsidiary in the UAE and operates through partners or distributors.
What is UTHR best known for?
The company is most famous for its development of innovative therapies for pulmonary arterial hypertension.
What assets are typically shown together with UTHR?
Commonly shown alongside UTHR: Immunome Inc, Intuitive Machines Inc, Seres Therapeutics Inc
Latest shares articles



